1. Repository of OAI
Ελληνικά   English  

Browsing by Author Tziomalos, K.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 4 to 14 of 14 < previous 
TitleAuthor(s)Issue date???itemlist.???
Effect of HMG-CoA reductase inhibitors on vascular cell apoptosis: beneficial or detrimental?Katsiki, N.; Tziomalos, K.; Chatzizisis, Y.; Elisaf, M. S.; Hatzitolios, A. I.24-Nov-2015-
Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised studyAthyros, V. G.; Mikhailidis, D. P.; Didangelos, T. P.; Giouleme, O. I.; Liberopoulos, E. N.; Karagiannis, A.; Kakafika, A. I.; Tziomalos, K.; Burroughs, A. K.; Elisaf, M. S.24-Nov-2015-
Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) StudyAthyros, V. G.; Mikhailidis, D. P.; Liberopoulos, E. N.; Kakafika, A. I.; Karagiannis, A.; Papageorgiou, A. A.; Tziomalos, K.; Ganotakis, E. S.; Elisaf, M. S.24-Nov-2015-
Identifying and attaining LDL-C goals: mission accomplished? Next target: new therapeutic options to raise HDL-C levelsAthyros, V. G.; Mikhailidis, D. P.; Kakafika, A. I.; Karagiannis, A.; Hatzitolios, A.; Tziomalos, K.; Ganotakis, E. S.; Liberopoulos, E. N.; Elisaf, M. S.24-Nov-2015-
Long-Term Impact of Multifactorial Treatment on New-Onset Diabetes and Related Cardiovascular Events in Metabolic Syndrome: A Post Hoc ATTEMPT AnalysisAthyros, V. G.; Elisaf, M. S.; Alexandrides, T.; Achimastos, A.; Ganotakis, E.; Bilianou, E.; Karagiannis, A.; Liberopoulos, E. N.; Tziomalos, K.; Mikhailidis, D. P.24-Nov-2015-
The role of renin-angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal?Karagiannis, A.; Mikhailidis, D. P.; Athyros, V. G.; Kakafika, A. I.; Tziomalos, K.; Liberopoulos, E. N.; Florentin, M.; Elisaf, M. S.24-Nov-2015-
Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT studyAthyros, V. G.; Giouleme, O.; Ganotakis, E. S.; Elisaf, M. S.; Tziomalos, K.; Vassiliadis, T.; Liberopoulos, E. N.; Theocharidou, E.; Karagiannis, A.; Mikhailidis, D. P.24-Nov-2015-
Should atenolol still be recommended as first-line therapy for primary hypertension?Karagiannis, A.; Athyros, V. G.; Papageorgiou, A.; Tziomalos, K.; Elisaf, M. S.24-Nov-2015-
Statin-based treatment for cardiovascular risk and non-alcoholic fatty liver disease. Killing two birds with one stone?Athyros, V. G.; Tziomalos, K.; Daskalopoulos, G. N.; Karagiannis, A.; Mikhailidis, D. P.24-Nov-2015-
Statin-Induced Increase in HDL-C and Renal Function in Coronary Heart Disease PatientsAthyros, V. G.; Kakafika, A. I.; Papageorgiou, A. A.; Pagourelias, E. D.; Savvatianos, S. D.; Elisaf, M. S.; Karagiannis, A.; Tziomalos, K.; Mikhailidis, D. P.24-Nov-2015-
Targeting vascular risk in patients with metabolic syndrome but without diabetesAthyros, V. G.; Mikhailidis, D. P.; Papageorgiou, A. A.; Didangelos, T. P.; Peletidou, A.; Kleta, D.; Karagiannis, A.; Kakafika, A. I.; Tziomalos, K.; Elisaf, M. S.24-Nov-2015-
Showing results 4 to 14 of 14 < previous